Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiyang Sun

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Plos One|July 22, 2017
Characterization of human enterovirus71 virus-like particles used for vaccine antigensDandan Zhao, Bo Sun, Shiyang Sun, et al.
European Journal of Medicinal Chemistry|October 18, 2023
Discovery of highly potent and selective KRAS<sup>G12C</sup> degraders by VHL-recruiting PROTACs for the treatment of tumors with KRAS<sup>G12C</sup>-MutationNing Yang, Zhiya Fan, Shiyang Sun, et al.
Bioorganic Chemistry|May 5, 2024
Exploration and structure-activity relationship research of benzenesulfonamide derivatives as potent TRPV4 inhibitors for treating acute lung injuryMengyuan Wang, Yuehao Zhang, Xu Cai, et al.
Oncology Research|October 6, 2025
Discovery and Characterization of Novel IKZF1/3 Glue Degraders against Multiple Hematological Cancer Cell LinesTing Wei, Pengli Wei, Yalei Wang, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn miceShiyang Sun, Liping Jiang, Zhenglun Liang, et al.
Plos One|June 26, 2014
Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assayHuafei Zhang, Dong An, Wei Liu, et al.
Journal of Medicinal Chemistry|July 16, 2025
Novel Highly Potent c-Met Degraders against a Broad Range of CancersChangkai Jia, Pengli Wei, Shiyang Sun, et al.
Journal of Medicinal Chemistry|August 1, 2025
Discovery of Novel Potent Triple IKZF1/2/3 Degraders for the Treatment of Hematological CancersTing Wei, Shiyang Sun, Xiaotong Hu, et al.
Journal of Medicinal Chemistry|March 20, 2026
Structure-Based Discovery of Novel, Highly Potent VEGFR2 Inhibitors with a Naphthalene Scaffold against a Broad Range of Solid TumorsTingting Yang, Ting Wei, Shiyang Sun, et al.
Journal of Hematology & Oncology|September 1, 2024
Novel potent molecular glue degraders against broad range of hematological cancer cell lines via multiple neosubstrates degradationPengyun Li, Xiaotong Hu, Zhiya Fan, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Plos One|July 22, 2017
Characterization of human enterovirus71 virus-like particles used for vaccine antigensDandan Zhao, Bo Sun, Shiyang Sun, et al.
European Journal of Medicinal Chemistry|October 18, 2023
Discovery of highly potent and selective KRAS<sup>G12C</sup> degraders by VHL-recruiting PROTACs for the treatment of tumors with KRAS<sup>G12C</sup>-MutationNing Yang, Zhiya Fan, Shiyang Sun, et al.
Bioorganic Chemistry|May 5, 2024
Exploration and structure-activity relationship research of benzenesulfonamide derivatives as potent TRPV4 inhibitors for treating acute lung injuryMengyuan Wang, Yuehao Zhang, Xu Cai, et al.
Oncology Research|October 6, 2025
Discovery and Characterization of Novel IKZF1/3 Glue Degraders against Multiple Hematological Cancer Cell LinesTing Wei, Pengli Wei, Yalei Wang, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn miceShiyang Sun, Liping Jiang, Zhenglun Liang, et al.
Plos One|June 26, 2014
Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assayHuafei Zhang, Dong An, Wei Liu, et al.
Journal of Medicinal Chemistry|July 16, 2025
Novel Highly Potent c-Met Degraders against a Broad Range of CancersChangkai Jia, Pengli Wei, Shiyang Sun, et al.
Journal of Medicinal Chemistry|August 1, 2025
Discovery of Novel Potent Triple IKZF1/2/3 Degraders for the Treatment of Hematological CancersTing Wei, Shiyang Sun, Xiaotong Hu, et al.
Journal of Medicinal Chemistry|March 20, 2026
Structure-Based Discovery of Novel, Highly Potent VEGFR2 Inhibitors with a Naphthalene Scaffold against a Broad Range of Solid TumorsTingting Yang, Ting Wei, Shiyang Sun, et al.
Journal of Hematology & Oncology|September 1, 2024
Novel potent molecular glue degraders against broad range of hematological cancer cell lines via multiple neosubstrates degradationPengyun Li, Xiaotong Hu, Zhiya Fan, et al.
Pageof 6